Bottom line
What is PCJRX's expense ratio?
PCJRX's expense ratio is 1.7%, or about $170 a year on every $10,000 invested. That is more expensive than 100% of target-date funds we track (median 0.59%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Feb 24, 2026
PCJRX fee table
| Net expense ratio | 1.7% |
|---|---|
| Gross expense ratio | 13.55% |
| Management fee | 0.54% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 11.38% |
| Acquired fund fees | 0.63% |
| Fee waiver / reimbursement | -11.85% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 24, 2026
What PCJRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCJRX | $273 | $536 | $3,274 | $8,230 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.7% expense ratio costs roughly $88,600 in lost growth, versus about $33,900 for the median target-date fund (0.59%).